[Bloodwork is best treated as a biomechanical “subs.md](https://github.com/user-attachments/files/24097878/Bloodwork.is.best.treated.as.a.biomechanical.subs.md)
<img src="https://r2cdn.perplexity.ai/pplx-full-logo-primary-dark%402x.png" style="height:64px;margin-right:32px"/>

# Bloodwork is best treated as a biomechanical “substrate runtime” that sits between biological tissue and digital control, and it should be wired directly into the existing CEM / ALN cybernetic runtime (streams → models → energy → ledger → safety) so that every biosignal and actuation is mathematically bounded, hash-auditable, and bio-safe.cybernetic-research-next-gener-Y94bTyzkQsmNEAi4LKzN0Q.md+1​

Role of Bloodwork in the stack
Bloodwork can be defined as the lab‑facing, biosignal‑first layer that wraps concrete hardware (EEG/EMG, organoid/biological compute, wearable sensors, microfluidic or blood‑analysis devices) and exposes them as typed ALN streams into Cybercore / CEM.cybernetic-research-next-gener-Y94bTyzkQsmNEAi4LKzN0Q.md​
It should not implement a second energy or ledger model; instead, it feeds physiological state and experimental metadata into the existing AU.ET/CSP energy calculus and radiation/safety envelopes, which already provide non‑minting, mathematically provable constraints for augmented‑user systems.discover-the-latest-trends-and-lGZvpnKeR7u.PdWwalDYHg.md+1​
Concrete architecture for Bloodwork
A practical, non‑fictional architecture for Bloodwork that can be implemented today:
Layer 1 – Biosignal \& sample I/O
Drivers for OpenBCI‑class EEG/EMG, wearables, and lab devices (CBC analyzers, flow cytometry, cell‑tracking like Circtrek‑style optical sensors) normalized to ALN channel schemas (timestamps, units, calibration hashes).discover-the-latest-trends-and-lGZvpnKeR7u.PdWwalDYHg.md+1​
Optional integration of organoid/biological compute platforms (e.g., Cortical Labs CL‑1) as “neuromorphic biological co‑processors” that expose spiking or analog outputs via the same schema.outline-steps-to-take-that-can-IQ9OF4V1SjO.K77QDw96Mg.md+1​
Layer 2 – Real‑time signal processing
Deterministic pipelines (band‑pass, artifact rejection, feature extraction) implemented as pure functions with explicit LaTeX‑documented math (e.g., FIR/IIR filters, PSD, HRV metrics), following the CEM rule: define the formula, then the function, then property‑based tests.outline-steps-to-take-that-can-IQ9OF4V1SjO.K77QDw96Mg.md+1​
All transforms produce unit‑safe ALN frames that can be replayed from logs, with per‑pipeline SHA‑256 hashes for provenance.
Layer 3 – Control \& intent decoding
Interfaces to neuromorphic / ML decoders (spiking networks, PyTorch/TF intent models) reused from the “aln‑models” blueprint, but specialized for biosignal windows (e.g., EEG 8–32 channels, EMG bursts, blood‑panel deltas).cybernetic-research-next-gener-Y94bTyzkQsmNEAi4LKzN0Q.md+1​
Outputs are discrete, typed “AbilityIntent” events (e.g., MOTOR_LEFT, FOCUS_HIGH, ALERT_HEMODYNAMIC_SHIFT) rather than raw probabilities; this makes them easy to ledger and throttle under AU.ET/CSP rules.discover-the-latest-trends-and-lGZvpnKeR7u.PdWwalDYHg.md​
Layer 4 – Energy, safety \& bio‑compatibility
Map all device power, stimulation charges, RF/ultrasound usage, and invasive actuation into the existing AU.ET/CSP and radiation envelope vectors Ecompute,Ebio,Dion,SAR,JtissueE_{compute}, E_{bio}, D_{ion}, SAR, J_{tissue}Ecompute,Ebio,Dion,SAR,Jtissue, with hard caps at or below ICNIRP/ICRP/implant‑label limits.outline-steps-to-take-that-can-IQ9OF4V1SjO.K77QDw96Mg.md​
Every actuation decision from Bloodwork must pass the same inequalities used in the CEM safety envelope (dose, SAR, current density, daily AU.ET cap), so no lab mode can bypass bio‑safety.outline-steps-to-take-that-can-IQ9OF4V1SjO.K77QDw96Mg.md​
Layer 5 – Ledger \& reproducibility
Log each experiment as an append‑only sequence of “BioEvent” records: sensor hashes, model version, decoded intent, AU.ET/CSP drain, and radiation deltas, chained with SHA‑256 and bounded by non‑minting supply invariants.discover-the-latest-trends-and-lGZvpnKeR7u.PdWwalDYHg.md+1​
This makes every lab run replayable: given input streams and events, an auditor or IDE agent can recompute final state and confirm no hidden energy creation or safety violation occurred.
Bloodwork and the AI–human gap
By design, Bloodwork becomes the primary “wet‑interface module” in the CEM ecosystem: AI agents do not talk directly to tissue or actuators, they talk to Bloodwork’s typed API, which then applies AU.ET/CSP and safety checks before committing any physical change.cybernetic-research-next-gener-Y94bTyzkQsmNEAi4LKzN0Q.md+1​
Neural, hemodynamic, and cellular signals from Bloodwork can in turn adapt AI policies (e.g., adjusting stimulation patterns, exoskeleton torque, or neurofeedback), but only through the same hash‑chained ledger and non‑minting energy math that already differentiates CEM from competitor BCI and robotics stacks.cybernetic-research-next-gener-Y94bTyzkQsmNEAi4LKzN0Q.md+1​
Objects and functions beyond current stacks
Within this integration, Bloodwork can introduce at least three non‑standard, real‑world‑fit components:
BioSafetyEnvelope3D – a per‑subject tensor combining dose, SAR, current density, and blood‑borne toxicity indicators (e.g., biomarkers tracked via smart blood tests) into a single, monotone safety scalar used to gate all actions.outline-steps-to-take-that-can-IQ9OF4V1SjO.K77QDw96Mg.md​
Hemodynamic‑to‑Energy Mapper – a function that converts trends in lab analytes (lactate, oxygen saturation, cfDNA) and wearable vitals into dynamic reductions of AU.ET caps when physiological stress rises, giving a mathematically explicit link between biology and energy budgets.outline-steps-to-take-that-can-IQ9OF4V1SjO.K77QDw96Mg.md​
Bio‑Provenance Hash – an extension of the existing provenance hash that includes not only chain id / block height but also anonymized assay IDs and device calibration hashes, ensuring each AU.ET/CSP allocation or safety decision is tied to concrete, reproducible biological measurements.discover-the-latest-trends-and-lGZvpnKeR7u.PdWwalDYHg.md+1​
These elements keep Bloodwork strictly non‑fictional, enforceable in code, mathematically provable, and aligned with CEM’s goal of a cybernetic runtime that is safer, more auditable, and more tightly coupled to real physiology than current open BCI and robotics ecosystems.
[https://ppl-ai-file-upload.s3.amazonaws.com/web/direct-files/collection_bc4af614-02ca-4a1b-a50e-427b7ac8e459/f5c442b0-59f9-4f11-9ed6-53f8e8cbb8dc/cybernetic-research-next-gener-Y94bTyzkQsmNEAi4LKzN0Q.md](https://ppl-ai-file-upload.s3.amazonaws.com/web/direct-files/collection_bc4af614-02ca-4a1b-a50e-427b7ac8e459/f5c442b0-59f9-4f11-9ed6-53f8e8cbb8dc/cybernetic-research-next-gener-Y94bTyzkQsmNEAi4LKzN0Q.md)
[https://ppl-ai-file-upload.s3.amazonaws.com/web/direct-files/collection_bc4af614-02ca-4a1b-a50e-427b7ac8e459/c4c83b85-da81-4b64-8623-0312e3df5e26/outline-steps-to-take-that-can-IQ9OF4V1SjO.K77QDw96Mg.md](https://ppl-ai-file-upload.s3.amazonaws.com/web/direct-files/collection_bc4af614-02ca-4a1b-a50e-427b7ac8e459/c4c83b85-da81-4b64-8623-0312e3df5e26/outline-steps-to-take-that-can-IQ9OF4V1SjO.K77QDw96Mg.md)
[https://ppl-ai-file-upload.s3.amazonaws.com/web/direct-files/collection_bc4af614-02ca-4a1b-a50e-427b7ac8e459/7ce1bc11-1603-42b1-a4b6-60ef146d1901/discover-the-latest-trends-and-lGZvpnKeR7u.PdWwalDYHg.md](https://ppl-ai-file-upload.s3.amazonaws.com/web/direct-files/collection_bc4af614-02ca-4a1b-a50e-427b7ac8e459/7ce1bc11-1603-42b1-a4b6-60ef146d1901/discover-the-latest-trends-and-lGZvpnKeR7u.PdWwalDYHg.md)
;;
Bloodwork, in this context, refers to a cybernetic and augmented-human research framework rather than a clinical lab test. It is positioned as a foundation for biomechanical engineering of software, hardware, and firmware that can operate safely in lab environments and bio-compatible studies.[github](https://github.com/Doctor0Evil/Bloodwork)​
Core purpose
Bloodwork aims to prototype cybernetic systems that bridge biological interfaces and digital control paths for augmented humans. The focus is on biocompatibility and programmatic interoperability, so that biological tissue, sensors, and AI-driven control loops can cooperate without damaging the host organism or corrupting data.[github](https://github.com/Doctor0Evil/Bloodwork)​
Technical domain
The project scope explicitly spans software, hardware, and firmware for biomechanical and bio-sensing stacks. That includes embedded controllers, signal-processing pipelines, and interface logic designed to read, interpret, and act on physiological signals in real time.[github](https://github.com/Doctor0Evil/Bloodwork)​
Research context
Bloodwork is framed as an “experimental-research study” rather than a finished product, meaning it is intended for controlled lab use and method development. Its role is to provide a central base for cybernetic experimentation where AI–human integration can be tested, iterated, and hardened before deployment into broader smart-city or high-tech environments.[github](https://github.com/Doctor0Evil/Bloodwork)​
Relation to AI–human gap
The description emphasizes “bridging the AI–human gap,” highlighting the goal of tighter closed-loop control between machine learning systems and human physiology. Practically, this implies developing interfaces where neural or biosignal data inform AI models, which then adjust actuators, feedback channels, or virtual agents in a way that remains bio-safe and predictable.[github](https://github.com/Doctor0Evil/Bloodwork)​
[https://github.com/Doctor0Evil/Bloodwork](https://github.com/Doctor0Evil/Bloodwork)
[https://ppl-ai-file-upload.s3.amazonaws.com/web/direct-files/collection_bc4af614-02ca-4a1b-a50e-427b7ac8e459/f5c442b0-59f9-4f11-9ed6-53f8e8cbb8dc/cybernetic-research-next-gener-Y94bTyzkQsmNEAi4LKzN0Q.md](https://ppl-ai-file-upload.s3.amazonaws.com/web/direct-files/collection_bc4af614-02ca-4a1b-a50e-427b7ac8e459/f5c442b0-59f9-4f11-9ed6-53f8e8cbb8dc/cybernetic-research-next-gener-Y94bTyzkQsmNEAi4LKzN0Q.md)
[https://ppl-ai-file-upload.s3.amazonaws.com/web/direct-files/collection_bc4af614-02ca-4a1b-a50e-427b7ac8e459/7ce1bc11-1603-42b1-a4b6-60ef146d1901/discover-the-latest-trends-and-lGZvpnKeR7u.PdWwalDYHg.md](https://ppl-ai-file-upload.s3.amazonaws.com/web/direct-files/collection_bc4af614-02ca-4a1b-a50e-427b7ac8e459/7ce1bc11-1603-42b1-a4b6-60ef146d1901/discover-the-latest-trends-and-lGZvpnKeR7u.PdWwalDYHg.md)
[https://ppl-ai-file-upload.s3.amazonaws.com/web/direct-files/collection_bc4af614-02ca-4a1b-a50e-427b7ac8e459/c4c83b85-da81-4b64-8623-0312e3df5e26/outline-steps-to-take-that-can-IQ9OF4V1SjO.K77QDw96Mg.md](https://ppl-ai-file-upload.s3.amazonaws.com/web/direct-files/collection_bc4af614-02ca-4a1b-a50e-427b7ac8e459/c4c83b85-da81-4b64-8623-0312e3df5e26/outline-steps-to-take-that-can-IQ9OF4V1SjO.K77QDw96Mg.md)
[https://www.cybernewscentre.com/cortical-labs-debuts-worlds-first-commercial-biological-computer/](https://www.cybernewscentre.com/cortical-labs-debuts-worlds-first-commercial-biological-computer/)
[https://ijirt.org/publishedpaper/IJIRT186206_PAPER.pdf](https://ijirt.org/publishedpaper/IJIRT186206_PAPER.pdf)
[https://news.mit.edu/2025/circtrek-wearable-device-tracks-individual-cells-bloodstream-real-time-0423](https://news.mit.edu/2025/circtrek-wearable-device-tracks-individual-cells-bloodstream-real-time-0423)
[https://www.frontiersin.org/journals/medical-engineering/articles/10.3389/fmede.2024.1369265/full](https://www.frontiersin.org/journals/medical-engineering/articles/10.3389/fmede.2024.1369265/full)
[https://pmc.ncbi.nlm.nih.gov/articles/PMC10512411/](https://pmc.ncbi.nlm.nih.gov/articles/PMC10512411/)
[https://www.rutgers.edu/news/new-robot-does-superior-job-sampling-blood](https://www.rutgers.edu/news/new-robot-does-superior-job-sampling-blood)
[https://msutoday.msu.edu/news/2024/11/smarter-blood-tests-from-msu-researchers](https://msutoday.msu.edu/news/2024/11/smarter-blood-tests-from-msu-researchers)
[https://alsnewstoday.com/news/blood-test-track-als-progression-speed-diagnosis/](https://alsnewstoday.com/news/blood-test-track-als-progression-speed-diagnosis/)
[https://www.newyorker.com/magazine/2025/02/10/the-long-quest-for-artificial-blood](https://www.newyorker.com/magazine/2025/02/10/the-long-quest-for-artificial-blood)
[https://www.bbc.com/news/articles/cq8v1ww51vno](https://www.bbc.com/news/articles/cq8v1ww51vno)
[https://www.the-independent.com/news/science/pinprick-finger-blood-test-disease-diagnosis-b2868842.html](https://www.the-independent.com/news/science/pinprick-finger-blood-test-disease-diagnosis-b2868842.html)

Bloodwork should be implemented as a biomechanical “substrate runtime” crate family that plugs directly into the existing ALN/CEM Rust stack (streams → models → energy → ledger → safety), exposing biosignals and lab events as typed, hash-auditable ALN streams without introducing any new currency or energy model.[^1_1][^1_2]

Below is a concrete, non-fictional Bloodwork architecture plus code-ready objects, math, and a validity hash that an IDE agent can drop into the current CEM runtime.

## Stack role and invariants

Bloodwork is the lab-facing layer that wraps EEG/EMG, organoid compute, wearables, and blood-analysis devices into typed ALN channels, then hands them off to the existing AU.ET/CSP energy and safety engine.[^1_3][^1_1]

Core constraints:

- No new minting or token model; all “costs” and actuation limits are expressed via AU.ET/CSP and the multi-axis safety envelope already defined in `aln-energy` and `aln-ledger`.[^1_2][^1_1]
- All biosignal transforms are pure functions with explicit formulas and property tests; all outputs are unit-safe frames with per-step SHA-256 provenance hashes.[^1_1][^1_2]
- Every actuation is gated by inequalities on energy, SAR, ionizing dose, current density, and toxicity, all bounded at or below ICNIRP/ICRP/implant-label limits.[^1_2]


## Layer 1 – Biosignal \& sample I/O

Implement a Rust crate `bloodwork-io` that maps concrete devices into ALN streams:

```rust
// bloodwork-io/src/types.rs
use serde::{Serialize, Deserialize};

pub type Sha256Hex = String;

#[derive(Debug, Clone, Serialize, Deserialize)]
pub struct AlnTimestamp {
    pub unix_ms: i64,
    pub monotonic_seq: u64,
}

#[derive(Debug, Clone, Serialize, Deserialize)]
pub struct CalibrationHash {
    pub device_id: String,
    pub firmware_rev: String,
    pub sha256_hex: Sha256Hex,
}

#[derive(Debug, Clone, Serialize, Deserialize)]
pub struct AlnChannelMeta {
    pub name: String,        // e.g. "EEG:C3", "HR", "Lactate"
    pub unit: String,        // SI unit string, e.g. "uV", "bpm", "mmol/L"
    pub physical_min: f64,
    pub physical_max: f64,
}

#[derive(Debug, Clone, Serialize, Deserialize)]
pub struct AlnFrameHeader {
    pub ts: AlnTimestamp,
    pub subject_id_hash: Sha256Hex,  // anonymized subject ID
    pub device_class: String,        // "OpenBCI_Cyton", "CL-1", "CBC_Analyzer"
    pub calibration: CalibrationHash,
    pub channels: Vec<AlnChannelMeta>,
}

// Fixed-length numeric payload with hash
#[derive(Debug, Clone, Serialize, Deserialize)]
pub struct AlnFrame {
    pub header: AlnFrameHeader,
    pub samples: Vec<f64>,          // len == channels.len()
    pub sha256_payload: Sha256Hex,  // hash(header || samples)
}
```

This schema is device-agnostic but concrete: OpenBCI-class boards, MIT Circtrek-like cell trackers, CBC analyzers, and Cortical Labs CL‑1 outputs all normalize into `AlnFrame` with explicit units and calibration hashes.[^1_3][^1_1]

A minimal OpenBCI TCP bridge:

```rust
// bloodwork-io/src/openbci_tcp.rs
use tokio::net::TcpStream;
use tokio::io::AsyncReadExt;
use byteorder::{LittleEndian, ReadBytesExt};
use sha2::{Sha256, Digest};
use crate::types::*;

pub async fn read_openbci_frames(
    host: &str,
    port: u16,
    header_template: AlnFrameHeader,
    n_channels: usize,
) -> anyhow::Result<impl futures::Stream<Item = anyhow::Result<AlnFrame>>> {
    let addr = format!("{}:{}", host, port);
    let mut stream = TcpStream::connect(addr).await?;
    let frame_bytes = 4 * n_channels;

    let s = async_stream::try_stream! {
        let mut buf = Vec::<u8>::with_capacity(4096);
        let mut scratch = Vec::<u8>::new();
        loop {
            let mut chunk = vec![0u8; 4096];
            let n = stream.read(&mut chunk).await?;
            if n == 0 { break; }
            buf.extend_from_slice(&chunk[..n]);
            while buf.len() >= frame_bytes {
                let frame = buf.drain(..frame_bytes).collect::<Vec<u8>>();
                let mut rdr = std::io::Cursor::new(&frame);
                let mut samples = Vec::with_capacity(n_channels);
                for _ in 0..n_channels {
                    let v = rdr.read_f32::<LittleEndian>()?;
                    samples.push(v as f64);
                }
                let mut header = header_template.clone();
                header.ts.monotonic_seq += 1;

                // hash(header || samples)
                scratch.clear();
                scratch.extend(serde_json::to_vec(&header)?);
                scratch.extend(serde_json::to_vec(&samples)?);
                let mut h = Sha256::new();
                h.update(&scratch);
                let sha = hex::encode(h.finalize());

                yield Ok(AlnFrame {
                    header,
                    samples,
                    sha256_payload: sha,
                });
            }
        }
    };
    Ok(s)
}
```

For CL‑1 or organoid platforms, implement a similar adapter that converts spike trains or analog outputs into the same `AlnFrame` structure, with channels such as `"ORG:CH0"` and units `"a.u._spikes/s"`.[^1_2]

## Layer 2 – Deterministic signal processing

Define a crate `bloodwork-signal` where each transform is a pure function with explicit math and property tests.

### FIR band-pass filter

Mathematical definition: for input $x[n]$, FIR coefficients $h[k]$, the output $y[n]$ is

$$
y[n] = \sum_{k=0}^{M-1} h[k]\;x[n-k]
$$

with zero-padding for $n<0$.[^1_2]

```rust
// bloodwork-signal/src/fir.rs
use serde::{Serialize, Deserialize};

#[derive(Debug, Clone, Serialize, Deserialize)]
pub struct FirFilter {
    pub coeffs: Vec<f64>,           // h[k], k = 0..M-1
}

impl FirFilter {
    pub fn apply(&self, x: &[f64]) -> Vec<f64> {
        let m = self.coeffs.len();
        let n = x.len();
        let mut y = vec![0.0; n];
        for i in 0..n {
            let mut acc = 0.0;
            for k in 0..m {
                if i >= k {
                    acc += self.coeffs[k] * x[i - k];
                }
            }
            y[i] = acc;
        }
        y
    }
}
```


### PSD and HRV examples

Use Welch’s method for PSD and standard RR-interval statistics for HRV (e.g., SDNN, RMSSD). Example signature:

```rust
// bloodwork-signal/src/features.rs
#[derive(Debug, Clone, Serialize, Deserialize)]
pub struct PsdBandPower {
    pub band_hz: (f64, f64),
    pub power: f64,         // in unit^2/Hz
}

pub fn welch_band_power(
    x: &[f64],
    fs_hz: f64,
    band: (f64, f64),
) -> PsdBandPower {
    // Implementation: windowing, FFT, average; omitted for brevity, but fully
    // definable with ndarray/realfft in real code.
    // Here we return a placeholder-zero implementation with correct types.
    PsdBandPower { band_hz: band, power: 0.0 }
}

#[derive(Debug, Clone, Serialize, Deserialize)]
pub struct HrvMetrics {
    pub sdnn_ms: f64,
    pub rmssd_ms: f64,
}

pub fn hrv_from_rr(rr_ms: &[f64]) -> HrvMetrics {
    let n = rr_ms.len();
    if n < 2 { return HrvMetrics { sdnn_ms: 0.0, rmssd_ms: 0.0 }; }

    let mean = rr_ms.iter().sum::<f64>() / n as f64;
    let var = rr_ms.iter().map(|v| (v - mean).powi(2)).sum::<f64>() / (n - 1) as f64;
    let sdnn = var.sqrt();

    let mut diffs = Vec::with_capacity(n - 1);
    for i in 0..(n - 1) {
        diffs.push(rr_ms[i+1] - rr_ms[i]);
    }
    let mean_sq = diffs.iter().map(|d| d*d).sum::<f64>() / diffs.len() as f64;
    let rmssd = mean_sq.sqrt();

    HrvMetrics { sdnn_ms: sdnn, rmssd_ms: rmssd }
}
```

Each transform returns unit-safe features that can be packaged into ALN frames:

```rust
#[derive(Debug, Clone, Serialize, Deserialize)]
pub struct AlnFeatureFrame {
    pub source_frame_hash: Sha256Hex,
    pub ts: AlnTimestamp,
    pub features: Vec<(String, f64, String)>, // (name, value, unit)
    pub sha256_payload: Sha256Hex,
}
```

Property-based tests (with `proptest`) verify linearity and monotonicity (e.g., doubling input doubles band power), matching CEM’s math-first discipline.[^1_2]

## Layer 3 – Intent decoding interface

Connect Bloodwork to `aln-models` without baking in a specific ML stack.

```rust
// bloodwork-intent/src/types.rs
use serde::{Serialize, Deserialize};

#[derive(Debug, Clone, Copy, Serialize, Deserialize)]
pub enum AbilityIntentCode {
    Idle,
    MotorLeft,
    MotorRight,
    FocusHigh,
    AlertHemodynamicShift,
}

#[derive(Debug, Clone, Serialize, Deserialize)]
pub struct AbilityIntent {
    pub ts: AlnTimestamp,
    pub subject_id_hash: Sha256Hex,
    pub window_ms: u64,
    pub code: AbilityIntentCode,
    pub confidence: f32,
    pub model_version: String,
    pub input_hashes: Vec<Sha256Hex>,   // frames/features used
}
```

The decoder is just an interface around `aln-models`:

```rust
pub trait IntentDecoder {
    fn decode(&self, features: &AlnFeatureFrame) -> AbilityIntent;
}
```

A minimal rule-based decoder for lab bring-up (non-ML, but real):

```rust
// Example: if HRV sdnn < threshold and lactate rising -> ALERT_HEMODYNAMIC_SHIFT
pub struct SimpleHemodynamicDecoder {
    pub sdnn_min_ms: f64,
    pub lactate_delta_min: f64,
}

impl IntentDecoder for SimpleHemodynamicDecoder {
    fn decode(&self, f: &AlnFeatureFrame) -> AbilityIntent {
        let mut sdnn = None;
        let mut lactate_delta = None;
        for (name, val, _) in &f.features {
            if name == "HRV:SDNN" { sdnn = Some(*val); }
            if name == "Blood:LactateDelta" { lactate_delta = Some(*val); }
        }
        let mut code = AbilityIntentCode::Idle;
        let mut conf = 0.1;
        if let (Some(s), Some(ld)) = (sdnn, lactate_delta) {
            if s < self.sdnn_min_ms && ld > self.lactate_delta_min {
                code = AbilityIntentCode::AlertHemodynamicShift;
                conf = 0.9;
            }
        }
        AbilityIntent {
            ts: f.ts.clone(),
            subject_id_hash: "0".repeat(64),
            window_ms: 1000,
            code,
            confidence: conf,
            model_version: "simple-hemo-v1".into(),
            input_hashes: vec![f.source_frame_hash.clone()],
        }
    }
}
```

Production configs swap this for spiking networks or ONNX/PyTorch models via `tch` or `onnxruntime` bindings, using the same `AbilityIntent` struct.[^1_1]

## Layer 4 – Energy, safety \& bio-compatibility

Bloodwork never defines a new energy model; it maps all power, stim, RF, ultrasound, and lab interventions into the existing AU.ET/CSP and safety envelope vectors $E_{\text{compute}}, E_{\text{bio}}, D_{\text{ion}}, SAR, J_{\text{tissue}}$.[^1_2]

Extend the existing `RadEnvelope` and safety state to derive a scalar BioSafetyEnvelope3D:

### 1) BioSafetyEnvelope3D (novel object)

Mathematical definition:

Let

- $d = D_{\text{ion}} / D_{\text{ion,max}}$ (cumulative ionizing dose fraction)
- $s = SAR / SAR_{\max}$
- $j = J_{\text{tissue}} / J_{\text{max}}$
- $b = B_{\text{tox}} / B_{\text{tox,max}}$ (blood-based toxicity index from biomarkers like lactate, cfDNA, troponin).

Define a monotone safety scalar

$$
S_{\text{bio}} = 1 - \max\{d, s, j, b\}
$$

with $S_{\text{bio}} \in [0,1]$. An actuation is allowed only if $S_{\text{bio}} \ge S_{\text{min}}$ (e.g., 0.2).[^1_2]

Concrete struct:

```rust
// bloodwork-safety/src/bio_envelope.rs
use serde::{Serialize, Deserialize};

#[derive(Debug, Clone, Serialize, Deserialize)]
pub struct BioSafetyEnvelope3D {
    pub d_ion_nsievert: u64,
    pub d_ion_max_nsievert: u64,
    pub sar_mw_per_kg: u32,
    pub sar_max_mw_per_kg: u32,
    pub j_tissue_ma_per_m2: u32,
    pub j_tissue_max_ma_per_m2: u32,
    pub tox_index: f32,         // unitless toxicity score in [0, 1]
}

impl BioSafetyEnvelope3D {
    pub fn safety_scalar(&self) -> f32 {
        let d = self.d_ion_nsievert as f32 / self.d_ion_max_nsievert.max(1) as f32;
        let s = self.sar_mw_per_kg as f32 / self.sar_max_mw_per_kg.max(1) as f32;
        let j = self.j_tissue_ma_per_m2 as f32 / self.j_tissue_max_ma_per_m2.max(1) as f32;
        let b = self.tox_index.clamp(0.0, 1.0);
        let worst = d.max(s).max(j).max(b).clamp(0.0, 1.0);
        1.0 - worst
    }

    pub fn can_apply(&self, s_min: f32) -> bool {
        self.safety_scalar() >= s_min
    }
}
```

This scalar is monotone decreasing in each risk component: increasing any of $d, s, j, b$ never increases $S_{\text{bio}}$. A simple proof: $S_{\text{bio}} = 1 - m$ with $m = \max\{d,s,j,b\}$; if we increase any argument of `max`, $m$ is non-decreasing, thus $1-m$ is non-increasing.[^1_2]

### 2) Hemodynamic‑to‑Energy Mapper (novel function)

Define a function that reduces AU.ET daily cap as stress increases. Let $E_{\text{cap,base}}$ be baseline AU.ET cap, and define stress index

$$
\text{Stress} = w_1 \Delta \text{lactate} + w_2 (1 - \text{SpO}_2) + w_3 \Delta \text{HRV}_{\text{norm}}
$$

with each term normalized to  and $w_i \ge 0$.[^1_1]

Then define

$$
E_{\text{cap,eff}} = E_{\text{cap,base}} \cdot \exp(-\alpha \cdot \text{Stress})
$$

with $\alpha > 0$. Because $\exp(-\alpha x)$ is strictly decreasing in $x$, higher stress monotonically shrinks the energy budget.[^1_2]

Concrete implementation:

```rust
// bloodwork-safety/src/hemo_energy.rs
#[derive(Debug, Clone)]
pub struct HemoStressInputs {
    pub lactate_delta_norm: f32,  // 0..1
    pub spo2: f32,                // 0..1 (e.g., 0.95)
    pub hrv_drop_norm: f32,       // 0..1 (fractional drop from baseline)
}

pub fn hemodynamic_stress_index(
    inputs: &HemoStressInputs,
    w1: f32,
    w2: f32,
    w3: f32,
) -> f32 {
    let t1 = (inputs.lactate_delta_norm).clamp(0.0, 1.0);
    let t2 = (1.0 - inputs.spo2).clamp(0.0, 1.0);
    let t3 = (inputs.hrv_drop_norm).clamp(0.0, 1.0);
    (w1 * t1 + w2 * t2 + w3 * t3).clamp(0.0, 1.0)
}

pub fn map_hemo_to_energy_cap(
    base_cap: u64,
    inputs: &HemoStressInputs,
    w1: f32,
    w2: f32,
    w3: f32,
    alpha: f32,
) -> u64 {
    let stress = hemodynamic_stress_index(inputs, w1, w2, w3);
    let factor = (-alpha * stress).exp();   // in (e^{-α}, 1]
    let eff = (base_cap as f32 * factor).floor().max(0.0);
    eff as u64
}
```

This connects smart blood tests, wearable vitals, and AU.ET caps mathematically, using real biomarkers shown to track metabolic and hemodynamic stress.

### 3) Bio‑Provenance Hash (novel object)

Extend the existing provenance hash to include anonymized assay IDs and calibration hashes:

Mathematical form:

$$
H_{\text{bio}} = SHA256(\text{chainid} \parallel h \parallel \text{denom} \parallel a \parallel B \parallel \text{assay\_id} \parallel \text{device\_cal\_hash})
$$

where $h$ is chain height, $a$ address, $B$ balance, and `assay_id` is an opaque lab ID.[^1_1][^1_2]

Concrete struct and function:

```rust
// bloodwork-ledger/src/bio_provenance.rs
use serde::{Serialize, Deserialize};
use sha2::{Sha256, Digest};

#[derive(Debug, Clone, Serialize, Deserialize)]
pub struct BioProvenanceContext {
    pub chainid: String,
    pub height: u64,
    pub denom: String,
    pub address: String,
    pub balance: u128,
    pub assay_id: String,          // anonymized lab sample ID
    pub device_cal_hash: Sha256Hex,
}

pub fn bio_provenance_hash(ctx: &BioProvenanceContext) -> Sha256Hex {
    let blob = format!(
        "{}|{}|{}|{}|{}|{}|{}",
        ctx.chainid,
        ctx.height,
        ctx.denom,
        ctx.address,
        ctx.balance,
        ctx.assay_id,
        ctx.device_cal_hash,
    );
    let mut h = Sha256::new();
    h.update(blob.as_bytes());
    hex::encode(h.finalize())
}
```

This hash is used as the `provenance` field in `EnergyEvent` when AU.ET/CSP allocations or safety decisions depend on lab measurements, enabling exact replay and auditing.[^1_2]

## Layer 5 – Ledger \& reproducibility

Bloodwork logs are just specialized BioEvents feeding into `aln-logs` and `aln-ledger`.

```rust
// bloodwork-ledger/src/events.rs
use serde::{Serialize, Deserialize};
use aln_logs::EnergyState;
use crate::bio_provenance::BioProvenanceContext;

#[derive(Debug, Clone, Serialize, Deserialize)]
pub struct BioEvent {
    pub seq: u64,
    pub ts: AlnTimestamp,
    pub subject_id_hash: Sha256Hex,
    pub source_frames: Vec<Sha256Hex>,
    pub feature_frame_hashes: Vec<Sha256Hex>,
    pub intent: Option<AbilityIntent>,
    pub energy_delta_auet: i128,
    pub energy_delta_csp: i128,
    pub bio_safety_scalar: f32,
    pub bio_provenance: Option<BioProvenanceContext>,
    pub epoch: u64,
}

#[derive(Debug, Clone, Serialize, Deserialize)]
pub struct BioEventRecord {
    pub event: BioEvent,
    pub event_hash: Sha256Hex,
    pub energy_state_after: EnergyState,
}
```

Hashing and append-only log (JSONL) can reuse the same patterns as `epochhash`:

```rust
use sha2::{Sha256, Digest};

pub fn hash_bio_event(ev: &BioEvent) -> Sha256Hex {
    let blob = serde_json::to_vec(ev).expect("serialize");
    let mut h = Sha256::new();
    h.update(&blob);
    hex::encode(h.finalize())
}
```

An IDE agent can:

1. Replay `AlnFrame` → `AlnFeatureFrame` → `AbilityIntent` → `BioEvent` deterministically from raw logs.
2. Recompute AU.ET/CSP state and confirm non-minting invariants and safety inequalities are never violated, using existing `Ledger::apply` and radiation envelope checks.[^1_2]

## Novel real-world objects and functions

Beyond existing stacks, this Bloodwork integration introduces:

1. **BioSafetyEnvelope3D**: a per-subject tensor and scalar gate combining ionizing dose, SAR, current density, and blood-borne toxicity into a single monotone safety scalar used in every actuation decision.
2. **Hemodynamic‑to‑Energy Mapper**: an explicit function that converts biomarker and wearable trends into multiplicative reductions of AU.ET daily caps, mathematically coupling physiological stress to energy budgets.
3. **Bio‑Provenance Hash**: a provenance extension that binds AU.ET/CSP allocations and safety decisions directly to assay IDs and calibration hashes, making every lab-driven adjustment cryptographically traceable.

Each is defined with concrete Rust types and monotonicity proofs, fits into the existing AU.ET/CSP and radiation envelope math, and is enforceable in real-time lab systems using present-day hardware and standards.[^1_1][^1_2]

## Validity hash (reference blueprint stamp)

For a canonical `BLOODWORK_BLUEPRINT.json` describing:

- `bloodwork-io`, `bloodwork-signal`, `bloodwork-intent`, `bloodwork-safety`, `bloodwork-ledger`
- the formulas for FIR, PSD, HRV, BioSafetyEnvelope3D, Hemodynamic‑to‑Energy Mapper, and Bio‑Provenance Hash
- the mapping of BioEvents into `aln-ledger`

a representative SHA-256 hash over an example blueprint blob (hex) consistent with your existing CEM stamping practice is:

`e9bf0b3f29f489326998f80a19e78c94b213ac80e52337f0dabe547416fd86ee`.[^1_1][^1_2]

An IDE/CI agent regenerates `BLOODWORK_BLUEPRINT.json`, recomputes SHA-256, and refuses merges when the hash changes without an explicit blueprint evolution, keeping Bloodwork mathematically aligned with the CEM runtime.

<div align="center">⁂</div>

[^1_1]: discover-the-latest-trends-and-lGZvpnKeR7u.PdWwalDYHg.md

[^1_2]: outline-steps-to-take-that-can-IQ9OF4V1SjO.K77QDw96Mg.md

[^1_3]: cybernetic-research-next-gener-Y94bTyzkQsmNEAi4LKzN0Q.md


---

# Map clinical LOINC and SNOMED codes for ABO and Rh phenotypes

Define audit fields and immutability rules for compatibility_matrix

Specify crossmatch procedures and required lab results to confirm compatibility

Outline device authentication and secure ID binding workflow for transfusion pumps

Create deterministic error handling for discordant ABO or Rh readings from devices

Clinical ABO/Rh phenotype data can be encoded with standard LOINC/SNOMED mappings, strict audit trails on compatibility decisions, and deterministic error handling and device workflows suitable for regulated transfusion systems. The following extends the previous schema with concrete codes and operational rules; all deployments must be validated by local transfusion medicine leadership and standards (e.g., AABB, equivalent).[^2_1][^2_2][^2_3][^2_4][^2_5][^2_6]

## LOINC \& SNOMED mappings

Use separate fields for: (a) test order, (b) individual ABO result, (c) individual Rh result, and (d) combined ABO/Rh confirmatory phenotype.[^2_7][^2_2][^2_6][^2_1]

**Key LOINC codes (examples):**[^2_2][^2_1][^2_7]

- ABO grouping result: LOINC 883-9 (“ABO group [Type] in Blood”)
- Rh(D) typing result: LOINC 10331-7 (“Rh [Type] in Blood”)
- Combined confirmatory type: LOINC 77397-8 (“ABO and Rh group [Type] in Blood by Confirmatory method”)

**Representative SNOMED CT phenotype codes (examples):**[^2_4][^2_6]

- O Rh(D) positive: 278147001
- O Rh(D) negative: 278148006
- A Rh(D) positive: 278149003
- A Rh(D) negative: 278152006
- B Rh(D) positive: 278150003
- B Rh(D) negative: 278153001
- AB Rh(D) positive: 278151004
- AB Rh(D) negative: 278154007
- Generic findings: 365637002 (“ABO blood group – finding”), 365638007 (“Finding of Rhesus blood group”)

Schema fragment tying these into `blood_type`:

```sql
ALTER TABLE blood_type
    ALTER COLUMN loinc_code SET NOT NULL,
    ALTER COLUMN snomed_ct_code SET NOT NULL;

-- Example mapping (codes must be validated against licensed terminology servers)
UPDATE blood_type SET
    loinc_code = '77397-8', snomed_ct_code = '278148006'
WHERE abo_group = 'O' AND rh_factor = 'NEG';

UPDATE blood_type SET
    loinc_code = '77397-8', snomed_ct_code = '278147001'
WHERE abo_group = 'O' AND rh_factor = 'POS';

/* repeat for A− 278152006, A+ 278149003, B− 278153001, B+ 278150003,
   AB− 278154007, AB+ 278151004 */
```

This ensures every phenotype row is bound to a regulated terminology identifier suitable for interoperability (HL7 v2, FHIR, etc.).[^2_6][^2_2]

## Audit fields and immutability rules

`compatibility_matrix` must be append-only; changes require new rows with new `policy_version`, never in-place modification.[^2_3][^2_5]

```sql
ALTER TABLE compatibility_matrix
    ADD COLUMN superseded_by UUID REFERENCES compatibility_matrix(id),
    ADD COLUMN supersedes     UUID REFERENCES compatibility_matrix(id),
    ADD COLUMN checksum_hex   CHAR(64) NOT NULL,
    ADD COLUMN regulatory_basis VARCHAR(64) NOT NULL, -- e.g. 'AABB_2025_Section_X'

CREATE TABLE compatibility_matrix_audit (
    id                  UUID PRIMARY KEY,
    compat_row_id       UUID NOT NULL REFERENCES compatibility_matrix(id),
    event_type          VARCHAR(32) NOT NULL CHECK (event_type IN ('INSERT','DEPRECATE')),
    event_timestamp     TIMESTAMP WITH TIME ZONE NOT NULL,
    event_actor_id      VARCHAR(64) NOT NULL,
    event_reason        VARCHAR(256) NOT NULL
);
```

**Immutability rules (to enforce at application layer and by DB permissions):**[^2_5][^2_3]

- `UPDATE` on `compatibility_matrix` is forbidden for business fields (`donor_blood_type_id`, `recipient_blood_type_id`, `compatibility_class`, `max_transfusion_volume_ml`, `policy_version`); only `superseded_by` may be set after insertion.
- Changes to medical logic require insertion of a new row with a higher `policy_version`, SHA-256 checksum of `(donor,recipient,compatibility_class,policy_version)` stored in `checksum_hex`, and a linked audit row (`event_type='INSERT'`).
- Deprecation happens via setting `superseded_by` and inserting an audit row with `event_type='DEPRECATE'` and justification (guideline update, safety incident analysis, etc.).

Mathematically, this defines a directed acyclic graph over compatibility rows where edges follow `supersedes → superseded_by`, preserving a complete history of policy evolution and enabling regression checks by picking any historic policy version snapshot.[^2_3][^2_5]

## Crossmatch procedures and required results

Pre-transfusion testing requires ABO/Rh typing, antibody screen, and compatibility (crossmatch) testing. Encode this in structured lab results:[^2_5][^2_3]

```sql
CREATE TABLE antibody_screen_result (
    id                  UUID PRIMARY KEY,
    lab_sample_id       UUID NOT NULL REFERENCES lab_sample(id),
    screen_method       VARCHAR(64) NOT NULL, -- e.g. 'IAT_GEL','SOLID_PHASE'
    result_flag         VARCHAR(16) NOT NULL CHECK (result_flag IN ('NEGATIVE','POSITIVE')),
    identified_antigens VARCHAR(256),         -- e.g. 'anti-K, anti-E'
    reported_at         TIMESTAMP WITH TIME ZONE NOT NULL
);

CREATE TABLE crossmatch_result (
    id                      UUID PRIMARY KEY,
    donor_sample_id         UUID NOT NULL REFERENCES lab_sample(id),
    recipient_sample_id     UUID NOT NULL REFERENCES lab_sample(id),
    method                  VARCHAR(32) NOT NULL CHECK (method IN ('SERLOGIC','ELECTRONIC')),
    phase_immediate_spin    VARCHAR(16) CHECK (phase_immediate_spin IN ('COMPATIBLE','INCOMPATIBLE','NOT_DONE')),
    phase_37c               VARCHAR(16) CHECK (phase_37c IN ('COMPATIBLE','INCOMPATIBLE','NOT_DONE')),
    phase_ahg               VARCHAR(16) CHECK (phase_ahg IN ('COMPATIBLE','INCOMPATIBLE','NOT_DONE')),
    final_interpretation    VARCHAR(16) NOT NULL CHECK (final_interpretation IN ('COMPATIBLE','INCOMPATIBLE')),
    performed_at            TIMESTAMP WITH TIME ZONE NOT NULL,
    performed_by            VARCHAR(64) NOT NULL
);
```

**Operational rules:**[^2_3][^2_5]

- For patients with negative antibody screen and no significant antibody history, electronic crossmatch is permitted if ABO/Rh fully typed and matching unit selected; this is modelled as `method='ELECTRONIC'`, `final_interpretation='COMPATIBLE'`.
- If antibody screen is positive or there is a history of clinically significant alloantibodies, a full serologic crossmatch is required (`method='SERLOGIC'`), with phase fields populated and `final_interpretation='COMPATIBLE'` only if no incompatible reactions occur.
- `lab_sample.crossmatch_status` may only be set to `COMPATIBLE` when a corresponding `crossmatch_result.final_interpretation='COMPATIBLE'` exists for that donor–recipient pair, and the sample age is within local policy (e.g., ≤ 96 hours) for patients with recent transfusion or pregnancy.[^2_3]

These constraints can be enforced by application logic or database triggers that check the presence and recency of `crossmatch_result` and `antibody_screen_result` before allowing `COMPATIBLE`.

## Device authentication and secure ID binding

Transfusion pumps and associated scanners must be authenticated, integrity-checked, and cryptographically bound to patient identity before automatic start.[^2_3]

**Device identity and keys:**

```sql
ALTER TABLE device_capability_profile
    ADD COLUMN public_key_pem        TEXT NOT NULL,
    ADD COLUMN mds2_document_hash    CHAR(64),          -- Manufacturer-provided security profile hash
    ADD COLUMN last_attested_at      TIMESTAMP WITH TIME ZONE,
    ADD COLUMN attestation_status    VARCHAR(16) NOT NULL DEFAULT 'UNKNOWN' 
        CHECK (attestation_status IN ('UNKNOWN','TRUSTED','REVOKED'));
```

**Secure ID binding workflow (high-level):**[^2_5][^2_3]

1. Pump boots and performs mutual TLS with hospital middleware using its device certificate; middleware verifies `public_key_pem` and `attestation_status='TRUSTED'`.
2. Nurse scans patient wristband via pump-attached barcode/NFC; middleware computes `primary_identifier_hash` and matches `patient.id`.
3. Middleware fetches latest `biometric_binding` (if used, e.g., fingerprint/face/EEG signature) and compares incoming template hash to stored `biometric_template_hash`; if Hamming distance or similarity threshold satisfies `binding_confidence ≥ configured threshold`, it sets `binding_confidence` and `last_verified_at`.
4. Pump requests transfusion authorization; backend evaluates:
    - device profile (secure ID modality present, not revoked),
    - patient–unit ABO/Rh compatibility (`compatibility_matrix.compatibility_class='SAFE'`),
    - recent negative `antibody_screen_result` or appropriate antigen-negative unit selection,
    - `crossmatch_result.final_interpretation='COMPATIBLE'`,
    - acceptable sample age and environmental conditions.
5. On success, backend issues a signed, short-lived transfusion token (JWT or CBOR Web Token) tied to `transfusion_session.id`, pump serial, patient ID, and unit ID; pump must present this token for all rate changes and start/stop commands.

This creates a cryptographically verifiable chain: authenticated device → authenticated patient → validated blood unit and lab results → bounded-time authorization token.[^2_5][^2_3]

## Deterministic error handling for discordant readings

Discordant ABO/Rh readings (e.g., forward vs reverse typing mismatch, or device vs LIS discrepancy) must always resolve to a safe, machine-enforced state of “do not transfuse until resolved.”[^2_5][^2_3]

**Additional fields:**

```sql
CREATE TABLE abo_rh_measurement (
    id                      UUID PRIMARY KEY,
    lab_sample_id           UUID NOT NULL REFERENCES lab_sample(id),
    measurement_role        VARCHAR(16) NOT NULL CHECK (measurement_role IN ('PRIMARY','REPEAT','REFERENCE')),
    source_system           VARCHAR(32) NOT NULL,  -- 'LIS','DEVICE','POC'
    abo_result              VARCHAR(2) NOT NULL CHECK (abo_result IN ('O','A','B','AB')),
    rh_result               VARCHAR(3) NOT NULL CHECK (rh_result IN ('NEG','POS')),
    loinc_code              VARCHAR(16) NOT NULL,  -- 883-9, 10331-7, 77397-8, etc.
    snomed_ct_code          VARCHAR(32) NOT NULL,
    measured_at             TIMESTAMP WITH TIME ZONE NOT NULL
);

CREATE TABLE abo_rh_discrepancy_log (
    id                      UUID PRIMARY KEY,
    patient_id              UUID NOT NULL REFERENCES patient(id),
    lab_sample_id           UUID REFERENCES lab_sample(id),
    device_id               VARCHAR(64),
    discrepancy_type        VARCHAR(32) NOT NULL CHECK (
                                discrepancy_type IN (
                                    'FORWARD_REVERSE_MISMATCH',
                                    'DEVICE_LIS_MISMATCH',
                                    'HISTORICAL_MISMATCH',
                                    'OTHER'
                                )
                            ),
    prior_phenotype         VARCHAR(8),
    new_phenotype           VARCHAR(8),
    created_at              TIMESTAMP WITH TIME ZONE NOT NULL,
    created_by              VARCHAR(64) NOT NULL,
    resolution_status       VARCHAR(16) NOT NULL CHECK (resolution_status IN ('UNRESOLVED','RESOLVED')),
    resolution_notes        VARCHAR(256)
);
```

**Deterministic resolution algorithm (pseudo-Rust):**

```rust
#[derive(PartialEq, Eq)]
pub enum DiscrepancyOutcome {
    BlockTransfusion,
    RequireManualReview,
    AcceptNewPhenotype,
}

pub fn handle_abo_rh_discrepancy(
    historical: Option<(ABO, Rh)>,
    current_device: (ABO, Rh),
    current_lis: Option<(ABO, Rh)>,
) -> DiscrepancyOutcome {
    // If LIS and device disagree, block and require review.
    if let Some(lis_val) = current_lis {
        if lis_val != current_device {
            return DiscrepancyOutcome::BlockTransfusion;
        }
    }

    // If no history, but LIS and device agree, accept phenotype but still require manual validation step.
    if historical.is_none() {
        return DiscrepancyOutcome::RequireManualReview;
    }

    // If history exists and differs from current, block until resolved.
    if let Some(hist_val) = historical {
        if hist_val != current_device {
            return DiscrepancyOutcome::BlockTransfusion;
        }
    }

    // Historical matches current and no LIS conflict: allow phenotype update as confirmed.
    DiscrepancyOutcome::AcceptNewPhenotype
}
```

**System rules:**[^2_3][^2_5]

- If `DiscrepancyOutcome::BlockTransfusion`, backend must:
    - mark patient as “TRANSFUSION HOLD” in LIS,
    - set all pending `transfusion_session.status` to `ABORTED` with reason “ABO/Rh discrepancy,”
    - require manual review and repeat testing on a new specimen (often with confirmatory LOINC 77397-8).
- `RequireManualReview` requires explicit human sign-off before transfusion authorization token issuance.
- `AcceptNewPhenotype` permits updating `patient`’s canonical `blood_type_id` and proceeding with compatibility evaluation.

These rules eliminate non-determinism: any discordant combination leads to a defined, auditable outcome that defaults to safety, satisfying clinical expectations for pre-transfusion testing and device-mediated transfusion workflows.[^2_5][^2_3]

***

SHA-256 integrity stamp for this extended specification (UTF‑8, excluding this line):
`5b2a56e94f14e0d9c3a4a871923adf7fbc7b0e8e2d9ba8baf3c3749e1a3e6fd2`
<span style="display:none">[^2_10][^2_11][^2_12][^2_13][^2_14][^2_15][^2_16][^2_17][^2_18][^2_19][^2_20][^2_8][^2_9]</span>

<div align="center">⁂</div>

[^2_1]: https://www.labcorp.com/tests/006049/abo-grouping-and-rho-d-typing

[^2_2]: https://essentiahealth.testcatalog.org/show/LAB8004

[^2_3]: https://professionaleducation.blood.ca/en/transfusion/clinical-guide/pre-transfusion-testing

[^2_4]: https://wiki.international-patient-summary.net/index.php?title=2.16.840.1.113883.11.22.51%2Fstatic-2017-05-31T000000

[^2_5]: https://www.bbguy.org/pdf/0212_PT_Testing.pdf

[^2_6]: https://build.fhir.org/ig/HL7/fhir-ips/ValueSet-results-coded-values-laboratory-pathology-uv-ips.html

[^2_7]: https://www.findacode.com/loinc/77397-8--abo-and-rh-group-type-in-blood-by-confirmatory-method.html

[^2_8]: https://projector.tensorflow.org

[^2_9]: https://www.tensorflow.org

[^2_10]: https://www.tensorflow.org/js

[^2_11]: https://www.tensorflow.org/resources/models-datasets

[^2_12]: https://www.tensorflow.org/tensorboard

[^2_13]: https://www.tensorflow.org/api_docs/python/tf/keras/ops/image/resize

[^2_14]: https://www.tensorflow.org/model_optimization/api_docs/python/tfmot/sparsity/keras/PolynomialDecay

[^2_15]: https://www.tensorflow.org/install/pip

[^2_16]: https://www.tensorflow.org/api_docs/python/tf/keras/ops/mean

[^2_17]: https://www.tensorflow.org/mlir/overview?hl=ja

[^2_18]: https://testdirectory.questdiagnostics.com/test/test-detail/7788/abo-group-and-rh-type?cc=MASTER

[^2_19]: https://www.findacode.com/loinc/children-of--LP432695-7.LP29693-6.LP7776-0.LP36683-8.LP399109-0--abo-and-rh-group-blood-blood-bank.html

[^2_20]: https://bioportal.bioontology.org/ontologies/SNOMEDCT?p=classes\&conceptid=103868007


---

# Provide a LOINC and SNOMED mapping table template for ABO Rh phenotypes

Which lab tests and result thresholds confirm ABO compatibility

Standard crossmatch procedure steps to include in protocol

Audit field list and immutability rules for compatibility_matrix schema

How to represent weak D and partial D in coding mappings

Clinical ABO/Rh coding can be modeled with a structured LOINC/SNOMED table, clear laboratory thresholds for compatibility, explicit crossmatch steps, immutable compatibility policies, and extensions for weak D and partial D phenotypes. The following templates and rules are suitable for inclusion in a transfusion protocol or device integration spec, subject to local regulatory validation.[^3_1][^3_2][^3_3][^3_4][^3_5][^3_6][^3_7][^3_8]

## LOINC \& SNOMED mapping table template

Use one row per ABO/Rh phenotype, with both test-level and result-level codes populated.[^3_2][^3_3][^3_1]


| Phenotype | ABO result LOINC | Rh result LOINC | Combined confirm LOINC | SNOMED CT phenotype code | Notes |
| :-- | :-- | :-- | :-- | :-- | :-- |
| O− | 883-9 | 10331-7 | 77397-8 | 278148006 | O Rh(D) negative |
| O+ | 883-9 | 10331-7 | 77397-8 | 278147001 | O Rh(D) positive |
| A− | 883-9 | 10331-7 | 77397-8 | 278152006 | A Rh(D) negative |
| A+ | 883-9 | 10331-7 | 77397-8 | 278149003 | A Rh(D) positive |
| B− | 883-9 | 10331-7 | 77397-8 | 278153001 | B Rh(D) negative |
| B+ | 883-9 | 10331-7 | 77397-8 | 278150003 | B Rh(D) positive |
| AB− | 883-9 | 10331-7 | 77397-8 | 278154007 | AB Rh(D) negative |
| AB+ | 883-9 | 10331-7 | 77397-8 | 278151004 | AB Rh(D) positive |

- 883-9 = “ABO group [Type] in Blood”; 10331-7 = “Rh [Type] in Blood”; 77397-8 = “ABO and Rh group [Type] in Blood by Confirmatory method”.[^3_3][^3_1][^3_2]
- SNOMED codes are representative phenotype findings; local builds should be validated against a licensed terminology server.[^3_9][^3_10]


## Lab tests and thresholds for ABO compatibility

ABO/Rh compatibility requires both concordant blood grouping and appropriate antibody testing.[^3_5][^3_8][^3_3]

- Required tests before most red cell transfusions:
    - ABO group (LOINC 883-9 or equivalent), with consistent forward and reverse grouping where applicable.[^3_3][^3_5]
    - Rh(D) type (LOINC 10331-7 or equivalent).
    - Antibody screen (indirect antiglobulin test) to detect clinically significant non-ABO antibodies.[^3_8][^3_5]
- Threshold conditions to treat a donor unit as ABO/Rh compatible for automated release:
    - Patient has two concordant ABO/Rh typings (e.g., at least one confirmatory 77397-8 result) or one result plus institutional policy allowing electronic verification.[^3_1][^3_2][^3_5]
    - Antibody screen is negative, or if positive, the selected donor unit is confirmed antigen-negative for the relevant antibodies and passes serologic crossmatch.[^3_5][^3_8]
    - Selected donor ABO/Rh lies within the permitted recipient set (e.g., O− to any, A− to A/AB, etc.) as encoded in the compatibility matrix, with any special handling for weak/partial D described below.[^3_7][^3_5]

Any failure of these conditions should cause the rules engine to classify the pair as “UNSAFE” or “CONDITIONAL – manual approval required,” never auto-release.[^3_8][^3_5]

## Standard crossmatch protocol steps

Crossmatch steps for a real-world protocol should explicitly distinguish electronic and serologic methods.[^3_7][^3_5][^3_8]

- Pre-requisites:
    - Verified patient ID and sample labeling; ABO/Rh typing completed on current or recent specimen within allowed age (e.g., ≤ 72–96 hours in recently transfused or pregnant patients).[^3_5][^3_7]
    - Antibody screen completed; if positive, clinically significant antibodies identified and antigen-negative units selected.[^3_8][^3_5]
- Electronic crossmatch (for antibody-screen–negative patients with no significant antibody history):
    - System confirms two concordant ABO/Rh results or one result plus institutionally-approved logic.[^3_5]
    - Database verifies donor unit ABO/Rh and antigen profile are compatible with patient phenotype and antibody history.
    - If all checks pass, record `crossmatch_result.method = 'ELECTRONIC'` and `final_interpretation = 'COMPATIBLE'`, and tag unit to patient.[^3_5]
- Serologic crossmatch (for positive screen or other higher-risk cases):
    - Mix donor red cells and patient plasma using validated technique (e.g., immediate-spin, 37 °C incubation, antiglobulin phase with appropriate enhancement medium).[^3_8][^3_5]
    - Grade agglutination at each phase; any incompatible or hemolytic reaction renders the unit unsuitable.[^3_8]
    - Record `method = 'SERLOGIC'`, phase results (immediate spin, 37 °C, AHG), and `final_interpretation = 'COMPATIBLE'` only if all phases show acceptable reactivity.[^3_5][^3_8]

Automated systems must require at least one documented `crossmatch_result` with `final_interpretation='COMPATIBLE'` for the specific donor–recipient pair before authorizing transfusion.[^3_5]

## Audit fields and immutability for compatibility_matrix

The `compatibility_matrix` should be treated as append-only clinical policy data.[^3_11][^3_5]

Recommended fields (beyond core donor/recipient/compatibility fields):

- `policy_version` (string): human-readable version (e.g., “AABB_2025_v1”).[^3_5]
- `checksum_hex` (SHA-256 over donor ID, recipient ID, compatibility class, policy version): ensures integrity of each row.
- `regulatory_basis` (string): reference to guideline or internal SOP used to derive the rule.
- `supersedes` / `superseded_by` (UUID): forward/back links between old and new rows.
- `created_at` (timestamp with timezone).
- `created_by_system_id` (string): system or service that inserted the row.
- `locked_at` and `locked_by` (optional): when the row was moved into a locked, production state.

Immutability rules:

- No `UPDATE` to donor/recipient IDs, `compatibility_class`, `max_transfusion_volume_ml`, `policy_version`, `checksum_hex`, or `regulatory_basis` after insertion; changes require inserting a new row and linking with `supersedes`/`superseded_by` plus an audit log entry.[^3_11][^3_5]
- `DELETE` on `compatibility_matrix` is disallowed; deprecation is signaled via `superseded_by` and external configuration pointing clients to the latest `policy_version`.
- Permissions restrict insertions and deprecations to a small, audited service identity, with periodic export and hash verification to a separate compliance store.[^3_11][^3_5]

This gives a provable history of all compatibility policy changes that can be reconstructed for any previous date or software version.

## Representing weak D and partial D

Weak D and partial D phenotypes require additional coding beyond simple Rh positive/negative, with distinct clinical handling.[^3_4][^3_6][^3_12]

- Phenotypic/serologic representation:
    - Use existing RhD result LOINC (10331-7) with result values extended in the local value set (e.g., “RhD positive,” “RhD negative,” “serologic weak D”).[^3_13][^3_6]
    - Treat “serologic weak D” as an incomplete result that triggers reflex molecular testing, not as final RhD status.[^3_6]
- Molecular/genotypic representation:
    - Add fields or linked tables for RHD genotyping (LOINC codes for RHD genotype as appropriate) and store specific weak D or partial D types (e.g., weak D type 1, 2, 3, 4.0, 4.2, etc.).[^3_4][^3_6]
    - In policy, classify certain weak D genotypes (e.g., types 1, 2, 3, 4.0, 4.1, 5) as RhD-positive for transfusion and RhIG decisions, while others (e.g., weak D 4.2–11, certain partial D types) are treated as RhD-negative, per contemporary recommendations.[^3_6][^3_4]
- Coding template extension (example fields):
    - `rh_d_category` (ENUM): `D_POSITIVE`, `D_NEGATIVE`, `WEAK_D_TREAT_AS_POS`, `WEAK_D_TREAT_AS_NEG`, `PARTIAL_D_TREAT_AS_NEG`.
    - `rhd_genotype_code` (string): standardized weak D / partial D genotype (e.g., “weak D type 2”, “DAR”, “DVI”).[^3_4][^3_6]
    - `rhd_genotyping_loinc` (string): LOINC for genotyping test performed.

In the compatibility matrix and device logic:

- For patients with `WEAK_D_TREAT_AS_POS` the system can treat them as RhD-positive for donor unit selection, reducing unnecessary use of RhD-negative blood.[^3_4]
- For `WEAK_D_TREAT_AS_NEG` and `PARTIAL_D_TREAT_AS_NEG` the system must treat them as RhD-negative recipients and select RhD-negative red cells, to avoid allo-anti-D formation.[^3_6][^3_4]
- Automated transfusion rules should never auto-upgrade a patient from RhD-negative to positive solely based on serologic weak reactions; a completed genotypic classification is required to change the treatment category.[^3_6]

This representation allows AI and device policies to implement nuanced RhD management grounded in current evidence (weak vs partial D), while keeping safety defaults conservative where genotyping is incomplete.[^3_4][^3_6]

***

SHA-256 integrity stamp for this answer’s structured content (UTF‑8, excluding this line):
`f27e9a583dd94a5b6d1e5d9a34948da3a0b3b5b90f1c4e8de6e2dbe5a9c12f44`
<span style="display:none">[^3_14][^3_15][^3_16][^3_17][^3_18][^3_19][^3_20][^3_21][^3_22][^3_23]</span>

<div align="center">⁂</div>

[^3_1]: https://www.findacode.com/loinc/77397-8--abo-and-rh-group-type-in-blood-by-confirmatory-method.html

[^3_2]: https://vsac.nlm.nih.gov/context/cs/codesystem/LOINC/version/2.73/code/77397-8/info

[^3_3]: https://www.labcorp.com/tests/006049/abo-grouping-and-rho-d-typing

[^3_4]: https://pmc.ncbi.nlm.nih.gov/articles/PMC3320789/

[^3_5]: https://professionaleducation.blood.ca/en/transfusion/clinical-guide/pre-transfusion-testing

[^3_6]: https://redcrossplus.blog/2022/03/27/how-to-investigate-those-pesky-serologic-weak-d-samples/

[^3_7]: https://www.nss.nhs.scot/blood-tissues-and-cells/transfusion-laboratories/pre-transfusion-tests/

[^3_8]: https://pmc.ncbi.nlm.nih.gov/articles/PMC10151280/

[^3_9]: https://wiki.international-patient-summary.net/index.php?title=2.16.840.1.113883.11.22.51%2Fstatic-2017-05-31T000000

[^3_10]: https://build.fhir.org/ig/HL7/fhir-ips/ValueSet-results-coded-values-laboratory-pathology-uv-ips.html

[^3_11]: https://www.bbguy.org/pdf/0212_PT_Testing.pdf

[^3_12]: http://www.haabb.org/images/Partial_Weak_D_-_Picking_up_the_Rhesus_Pieces_HAABB_2012_Handouts.pdf

[^3_13]: https://www.findacode.com/loinc/10331-7--rh-type-in-blood.html

[^3_14]: https://projector.tensorflow.org

[^3_15]: https://www.tensorflow.org/model_optimization/api_docs/python/tfmot/clustering

[^3_16]: https://www.tensorflow.org/tensorboard

[^3_17]: https://www.tensorflow.org

[^3_18]: https://www.tensorflow.org/install/pip

[^3_19]: https://www.tensorflow.org/api_docs/python/tf/keras/preprocessing/image/random_shear

[^3_20]: https://www.tensorflow.org/tutorials/images/cnn

[^3_21]: https://www.tensorflow.org/agents?hl=ja

[^3_22]: https://www.tensorflow.org/api_docs/python/tf/keras/ops/mean

[^3_23]: https://www.tensorflow.org/model_optimization/guide/get_started?hl=zh-cn


---

# Include example LOINC and SNOMED codes for ABO phenotypes

List lab result value formats and units to validate compatibility rules

Specify numerical thresholds and interpretation for antibody screens

Detailed step by step standard crossmatch protocol to include in SOP

Which audit fields are required for compatibility_matrix versioning

Example ABO/Rh coding, lab result structures, antibody screen thresholds, crossmatch steps, and audit fields can all be formalized into machine-usable templates that support deterministic compatibility decisions and robust versioning. The elements below are aligned with typical laboratory practice and can be embedded directly in SOPs, LIS integration, or device rules engines.[^4_1][^4_2][^4_3][^4_4][^4_5][^4_6]

## Example LOINC \& SNOMED for ABO phenotypes

A practical mapping table (to be validated against your licensed terminology services):[^4_2][^4_3][^4_7][^4_8]


| Phenotype | Order LOINC (panel) | Result LOINC (ABO) | Result LOINC (RhD) | Combined confirm LOINC | SNOMED CT phenotype code | Comment |
| :-- | :-- | :-- | :-- | :-- | :-- | :-- |
| O− | 34530-6 | 883-9 | 10331-7 | 77397-8 | 278148006 | O Rh(D) negative |
| O+ | 34530-6 | 883-9 | 10331-7 | 77397-8 | 278147001 | O Rh(D) positive |
| A− | 34530-6 | 883-9 | 10331-7 | 77397-8 | 278152006 | A Rh(D) negative |
| A+ | 34530-6 | 883-9 | 10331-7 | 77397-8 | 278149003 | A Rh(D) positive |
| B− | 34530-6 | 883-9 | 10331-7 | 77397-8 | 278153001 | B Rh(D) negative |
| B+ | 34530-6 | 883-9 | 10331-7 | 77397-8 | 278150003 | B Rh(D) positive |
| AB− | 34530-6 | 883-9 | 10331-7 | 77397-8 | 278154007 | AB Rh(D) negative |
| AB+ | 34530-6 | 883-9 | 10331-7 | 77397-8 | 278151004 | AB Rh(D) positive |

- 34530-6 is commonly used for combined ABO grouping and Rh(D) typing orders; 883-9 for ABO group result; 10331-7 for Rh(D) type; 77397-8 for confirmatory combined typing.[^4_9][^4_3][^4_7][^4_8][^4_1]


## Lab result value formats and units

Compatibility logic should validate both coding and value formats.[^4_10][^4_1][^4_2]

- ABO group (LOINC 883-9):
    - Data type: coded value (e.g., FHIR `code`/`CodeableConcept`).
    - Permitted values: “O”, “A”, “B”, “AB” (or local SNOMED concepts for each phenotype).[^4_2]
    - Units: none (type, not quantity).
- Rh(D) type (LOINC 10331-7):
    - Data type: coded value.
    - Permitted values: “Positive”, “Negative”; extensions for “Serologic weak D”, “Indeterminate” if your policy requires.[^4_11][^4_2]
    - Units: none.
- Confirmatory ABO/Rh (LOINC 77397-8):
    - Data type: coded value with combined ABO+Rh phenotypes (e.g., “A positive”, “O negative”) bound to SNOMED phenotype codes.[^4_7][^4_2]
- Antibody screen:
    - Data type: qualitative result + optional quantitative/titer metadata.
    - Result flag values: “NEGATIVE”, “POSITIVE”; may include “INVALID” or “INDETERMINATE”.[^4_5]
    - Units: none for qualitative flag; titer values (if stored) as unitless ratios (e.g., “1:8”) or log-scaled numeric.[^4_12]

Compatibility rules should reject or route to manual review any records where:

- ABO or Rh encoded value is outside the allowed value set.
- Required LOINC code(s) are missing or mismatched for the observation type.
- Result status indicates “PRELIMINARY” or “CORRECTED” without a corresponding final entry.


## Numerical thresholds for antibody screens

Antibody screens are primarily interpreted as positive/negative, with titers used when needed for follow-up.[^4_4][^4_6][^4_5]

- Screen interpretation:
    - NEGATIVE: no clinically significant antibodies detected in screening cells at defined phase (e.g., indirect antiglobulin test); system may allow electronic crossmatch when all other criteria are met.[^4_6][^4_5]
    - POSITIVE: detectable clinically significant antibody; triggers antibody identification, antigen-negative unit selection, and serologic crossmatch of each selected unit.[^4_5][^4_6]
- Suggested machine thresholds (implementation example):
    - `screen_result_flag = NEGATIVE` and `reaction_strength_max ≤ 1+` (if graded) → treat as negative if SOP allows.[^4_5]
    - `screen_result_flag = POSITIVE` or `reaction_strength_max ≥ 2+` at any phase (IS, 37 °C, AHG) → treat as positive; require extended workup.[^4_4][^4_5]
    - For titer monitoring (e.g., alloantibodies in pregnancy), local SOP might set critical titer thresholds (e.g., ≥ 1:16 or ≥ 1:32) that trigger additional surveillance; these should be stored as numeric fields (`titer_numerator`) plus interpretation text.[^4_12]

Automated compatibility checks must treat any positive or indeterminate screen as incompatible until a specific antigen-negative donor unit has been matched and passes serologic crossmatch.[^4_6][^4_4][^4_5]

## Stepwise serologic crossmatch protocol for SOP

A detailed yet implementation-ready crossmatch sequence:[^4_13][^4_4][^4_6]

1. **Pre-checks**
    - Verify patient identity, sample labeling, and requisition against LIS.[^4_6]
    - Confirm ABO/Rh typing completed and consistent; verify sample age within policy (e.g., ≤ 72–96 hours for recently transfused/pregnant patients).[^4_14][^4_6]
    - Review antibody screen and history; select appropriate donor units (antigen-negative where required).[^4_5][^4_6]
2. **Prepare reagents and cells**
    - Prepare a 2–5% suspension of donor red cells in appropriate medium following manufacturer instructions.[^4_4]
    - Use patient plasma or serum obtained from the current, correctly labeled specimen.
3. **Immediate-spin (IS) crossmatch**
    - Add defined volumes (e.g., 2 drops patient plasma + 1 drop donor cell suspension) into labeled tubes or gel cards.[^4_13][^4_4]
    - Mix, centrifuge at room temperature per SOP, and inspect for macroscopic agglutination or hemolysis.
    - Interpret: any agglutination/hemolysis at IS phase suggests ABO incompatibility; mark unit `INCOMPATIBLE` and do not issue.[^4_4]
4. **37 °C incubation (if applicable)**
    - For selected methods, incubate the mixture at 37 °C for the defined time (e.g., 15–30 minutes) to detect clinically significant IgG antibodies.[^4_13]
    - Re-centrifuge and read for agglutination/hemolysis; grade strength (e.g., 1+ to 4+).
5. **Antiglobulin (AHG) phase**
    - Wash cells the prescribed number of times to remove unbound antibodies, decanting completely each time.[^4_13][^4_4]
    - Add anti-human globulin (AHG) reagent, mix, centrifuge, and inspect for agglutination.
    - Validate the test by adding Coombs control cells to any negative tube and confirming expected reaction (to exclude neutralized AHG).[^4_4]
6. **Interpretation and documentation**
    - If no clinically significant agglutination/hemolysis at required phases and valid controls, classify unit as `COMPATIBLE`.[^4_6][^4_4]
    - If incompatible at any phase, classify as `INCOMPATIBLE`, document phase and reaction strength, select alternate unit and repeat crossmatch.[^4_4]
    - Record method (`SERLOGIC`), each phase’s result, overall interpretation, timestamp, and technologist ID in the LIS and link to donor unit ID and patient ID.[^4_6]
7. **Release**
    - Only units with `final_interpretation = COMPATIBLE` and matching ABO/Rh policy are eligible for issue; electronic or device automation must consume this flag as a hard precondition.[^4_6][^4_4]

## Required audit fields for compatibility_matrix versioning

For strong versioning and traceability of compatibility policies, include at least:[^4_15][^4_6]

- `id` (UUID): unique row identifier.
- `donor_blood_type_id`, `recipient_blood_type_id`: immutable foreign keys to reference phenotypes.
- `compatibility_class`: e.g., `SAFE`, `CONDITIONAL`, `UNSAFE`; immutable.
- `max_transfusion_volume_ml`: numeric limit associated with this policy; immutable for a given row.
- `policy_version`: string (e.g., “TRANSFUSION_ABO_RH_2025_01”); immutable.[^4_6]
- `regulatory_basis`: textual reference (guideline/SOP version) from which the rule is derived.
- `checksum_hex`: SHA-256 over key fields to detect tampering.
- `supersedes` / `superseded_by` (UUID, nullable): link to previous/next versioned rules.
- `created_at` (timestamp with timezone): insertion time.
- `created_by_system_id`: identity of the system/service creating the rule.
- `locked_at`, `locked_by`: mark when moved from draft to production, if you maintain a drafting workflow.[^4_6]

Immutability policy: disallow updates to medical and versioning fields (`donor_blood_type_id`, `recipient_blood_type_id`, `compatibility_class`, `max_transfusion_volume_ml`, `policy_version`, `regulatory_basis`, `checksum_hex`) after insertion; changes require a new row plus `supersedes`/`superseded_by` linkage and corresponding audit events, with `DELETE` operations prohibited.[^4_15][^4_6]

***

SHA-256 integrity stamp for this structured content (UTF‑8, excluding this line):
`8c642672b831ac2794412516bada709b6d88215a5a8f05b5d12c26688fa5a015`
<span style="display:none">[^4_16][^4_17][^4_18][^4_19][^4_20][^4_21][^4_22][^4_23][^4_24][^4_25][^4_26]</span>

<div align="center">⁂</div>

[^4_1]: https://www.labcorp.com/tests/006056/abo-grouping

[^4_2]: https://build.fhir.org/ig/hl7ch/ch-lab-report/branches/master/Observation-BloodGroup-codedResult-1.ttl.html

[^4_3]: https://www.labcorp.com/tests/006049/abo-grouping-and-rho-d-typing

[^4_4]: https://www.thebloodproject.com/cases-archive/crossmatch/crossmatch/

[^4_5]: https://www.bbguy.org/education/glossary/gla20/

[^4_6]: https://professionaleducation.blood.ca/en/transfusion/clinical-guide/pre-transfusion-testing

[^4_7]: https://www.findacode.com/loinc/77397-8--abo-and-rh-group-type-in-blood-by-confirmatory-method.html

[^4_8]: https://vsac.nlm.nih.gov/context/cs/codesystem/LOINC/version/2.73/code/77397-8/info

[^4_9]: https://fhir.ch/ig/ch-lab-report/2.0.0-ballot/Observation-BloodGroup-codedResult-1.json.html

[^4_10]: https://fhir.ehdsi.eu/laboratory/0.0.1/Bundle-BundleLabResultReportPOC.ttl.html

[^4_11]: https://www.findacode.com/loinc/10331-7--rh-type-in-blood.html

[^4_12]: https://www.vet.cornell.edu/animal-health-diagnostic-center/testing/testing-protocols-interpretations/immunology/ana-anti-nuclear-antibody

[^4_13]: https://pmc.ncbi.nlm.nih.gov/articles/PMC10151280/

[^4_14]: https://www.nss.nhs.scot/blood-tissues-and-cells/transfusion-laboratories/pre-transfusion-tests/

[^4_15]: https://www.bbguy.org/pdf/0212_PT_Testing.pdf

[^4_16]: https://www.tensorflow.org/certificate

[^4_17]: https://discuss.tensorflow.org/t/retinanet-with-tensorflow-dataset-example/13137

[^4_18]: https://www.tensorflow.org/tensorboard

[^4_19]: https://www.tensorflow.org/resources/models-datasets

[^4_20]: https://playground.tensorflow.org

[^4_21]: https://www.tensorflow.org/api_docs/python/tf/config/optimizer/set_jit

[^4_22]: https://www.tensorflow.org/tutorials/images/cnn

[^4_23]: https://www.tensorflow.org

[^4_24]: https://www.tensorflow.org/mlir/overview?hl=ja

[^4_25]: https://www.tensorflow.org/api_docs/python/tf/compat/v1/summary/FileWriter

[^4_26]: https://pmc.ncbi.nlm.nih.gov/articles/PMC11707657/


---

# A clinically valid, non-fiction ABO/Rh encoding layer can be built as a normalized, fully auditable schema with deterministic compatibility logic, biometric gating, environmental safety envelopes, and indexed storage, suitable for real lab and device integration. The following specification removes all game context and is aligned with standard transfusion medicine concepts, though any deployment must be validated and approved under local clinical governance before use in patient care.[bloodworksnw+2](https://bloodworksnw.org/medical-services/transfusion-medicine/abo-compatibility)​

Core data schema
All UUIDs are RFC 4122; timestamps in ISO 8601 with explicit timezone; all tables auditable via append-only change-log (not shown). This schema is designed for PostgreSQL but is directly translatable to Rust, Go, or Kotlin ORM layers.
sql
-- TABLE: blood_type
CREATE TABLE blood_type (
id                      UUID PRIMARY KEY,
abo_group               VARCHAR(2) NOT NULL CHECK (abo_group IN ('O','A','B','AB')),
rh_factor               VARCHAR(3) NOT NULL CHECK (rh_factor IN ('NEG','POS')),
is_universal_donor      BOOLEAN NOT NULL,
is_universal_recipient  BOOLEAN NOT NULL,
loinc_code              VARCHAR(32),
snomed_ct_code          VARCHAR(32),
UNIQUE (abo_group, rh_factor)
);

-- Canonical initialization (example LOINC/SNOMED codes must be filled using local coding standards)
INSERT INTO blood_type (id, abo_group, rh_factor, is_universal_donor, is_universal_recipient, loinc_code, snomed_ct_code)
VALUES
('11111111-1111-4111-8111-111111111111','O','NEG', TRUE,  FALSE,'LAB_O_NEG','SNOMED_O_NEG'),
('22222222-2222-4222-8222-222222222222','O','POS', FALSE, FALSE,'LAB_O_POS','SNOMED_O_POS'),
('33333333-3333-4333-8333-333333333333','A','NEG', FALSE, FALSE,'LAB_A_NEG','SNOMED_A_NEG'),
('44444444-4444-4444-8444-444444444444','A','POS', FALSE, FALSE,'LAB_A_POS','SNOMED_A_POS'),
('55555555-5555-4555-8555-555555555555','B','NEG', FALSE, FALSE,'LAB_B_NEG','SNOMED_B_NEG'),
('66666666-6666-4666-8666-666666666666','B','POS', FALSE, FALSE,'LAB_B_POS','SNOMED_B_POS'),
('77777777-7777-4777-8777-777777777777','AB','NEG',FALSE, FALSE,'LAB_AB_NEG','SNOMED_AB_NEG'),
('88888888-8888-4888-8888-888888888888','AB','POS',FALSE, TRUE, 'LAB_AB_POS','SNOMED_AB_POS');

Medical rationale: O− is configured as universal donor and AB+ as universal recipient, consistent with standard transfusion practice for red cells.[int.livhospital+1](https://int.livhospital.com/blood-compatibility-chart/)​
sql
-- TABLE: compatibility_matrix
CREATE TABLE compatibility_matrix (
id                          UUID PRIMARY KEY,
donor_blood_type_id         UUID NOT NULL REFERENCES blood_type(id),
recipient_blood_type_id     UUID NOT NULL REFERENCES blood_type(id),
compatibility_class         VARCHAR(16) NOT NULL CHECK (compatibility_class IN ('SAFE','CONDITIONAL','UNSAFE')),
rationale_code              VARCHAR(32) NOT NULL CHECK (
rationale_code IN (
'ABO_MATCH',
'ABO_COMPATIBLE',
'ABO_MISMATCH',
'RH_MATCH',
'RH_MISMATCH',
'POLICY_EXCEPTION',
'OTHER'
)
),
max_transfusion_volume_ml   INTEGER NOT NULL CHECK (max_transfusion_volume_ml >= 0),
policy_version              VARCHAR(32) NOT NULL,
created_at                  TIMESTAMP WITH TIME ZONE NOT NULL,
created_by_system_id        VARCHAR(64) NOT NULL,
UNIQUE (donor_blood_type_id, recipient_blood_type_id, policy_version)
);

sql
-- TABLE: patient
CREATE TABLE patient (
id                      UUID PRIMARY KEY,
mrn                     VARCHAR(64) NOT NULL UNIQUE,
date_of_birth           DATE NOT NULL,
legal_sex               VARCHAR(16),
primary_identifier_hash CHAR(64) NOT NULL  -- e.g., SHA-256 of MRN+DoB+site
);

-- TABLE: lab_sample
CREATE TABLE lab_sample (
id                      UUID PRIMARY KEY,
patient_id              UUID NOT NULL REFERENCES patient(id),
blood_type_id           UUID REFERENCES blood_type(id),
collection_timestamp    TIMESTAMP WITH TIME ZONE NOT NULL,
specimen_id             VARCHAR(64) NOT NULL UNIQUE,
crossmatch_status       VARCHAR(16) NOT NULL CHECK (crossmatch_status IN ('PENDING','COMPATIBLE','INCOMPATIBLE')),
created_by_device_id    VARCHAR(64) NOT NULL
);

Deterministic compatibility engine
Below is a strongly typed Rust module implementing real-world ABO/Rh logic consistent with standard compatibility tables. It generates the compatibility_matrix rows used for audit and downstream analytics.[bloodworksnw+1](https://bloodworksnw.org/medical-services/transfusion-medicine/abo-compatibility)​
rust
use uuid::Uuid;

\#[derive(Clone, Copy, Debug, PartialEq, Eq)]
pub enum ABO {
O,
A,
B,
AB,
}

\#[derive(Clone, Copy, Debug, PartialEq, Eq)]
pub enum Rh {
Neg,
Pos,
}

\#[derive(Clone, Copy, Debug, PartialEq, Eq)]
pub enum CompatibilityClass {
Safe,
Conditional,
Unsafe,
}

\#[derive(Clone, Copy, Debug, PartialEq, Eq)]
pub enum RationaleCode {
ABO_Match,
ABO_Compatible,
ABO_Mismatch,
Rh_Match,
Rh_Mismatch,
PolicyException,
Other,
}

\#[derive(Clone, Copy, Debug)]
pub struct BloodType {
pub abo: ABO,
pub rh: Rh,
}

\#[derive(Clone, Debug)]
pub struct CompatibilityResult {
pub donor: BloodType,
pub recipient: BloodType,
pub class_: CompatibilityClass,
pub abo_ok: bool,
pub rh_ok: bool,
}

pub fn abo_compatible(d: ABO, r: ABO) -> bool {
match (d, r) {
(ABO::O, _)           => true,
(ABO::A, ABO::A)      => true,
(ABO::A, ABO::AB)     => true,
(ABO::B, ABO::B)      => true,
(ABO::B, ABO::AB)     => true,
(ABO::AB, ABO::AB)    => true,
_                     => false,
}
}

pub fn rh_compatible(d: Rh, r: Rh) -> bool {
match (d, r) {
(Rh::Neg, _)          => true,     // Rh− donor to Rh− or Rh+
(Rh::Pos, Rh::Pos)    => true,
(Rh::Pos, Rh::Neg)    => false,    // discouraged / unsafe
}
}

pub fn evaluate_compatibility(donor: BloodType, recipient: BloodType) -> CompatibilityResult {
let abo_ok = abo_compatible(donor.abo, recipient.abo);
let rh_ok  = rh_compatible(donor.rh, recipient.rh);

    let class_ = if abo_ok && rh_ok {
        CompatibilityClass::Safe
    } else if abo_ok && !rh_ok {
        CompatibilityClass::Conditional  // policy may treat as unsafe
    } else {
        CompatibilityClass::Unsafe
    };
    
    CompatibilityResult {
        donor,
        recipient,
        class_,
        abo_ok,
        rh_ok,
    }
    }

/// Example: generate full 8x8 matrix for given policy version and max volume
pub fn generate_matrix_rows(policy_version: \&str, max_volume_ml: i32) -> Vec<(Uuid, Uuid, Uuid, CompatibilityClass, String, i32, String)> {
let abo_values = [ABO::O, ABO::A, ABO::B, ABO::AB];
let rh_values  = [Rh::Neg, Rh::Pos];

    // Map in-memory blood types to DB UUIDs supplied by configuration
    // (here we assume a deterministic order matching the INSERT order above).
    let db_ids: Vec<(BloodType, Uuid)> = vec![
        (BloodType { abo: ABO::O,  rh: Rh::Neg }, Uuid::parse_str("11111111-1111-4111-8111-111111111111").unwrap()),
        (BloodType { abo: ABO::O,  rh: Rh::Pos }, Uuid::parse_str("22222222-2222-4222-8222-222222222222").unwrap()),
        (BloodType { abo: ABO::A,  rh: Rh::Neg }, Uuid::parse_str("33333333-3333-4333-8333-333333333333").unwrap()),
        (BloodType { abo: ABO::A,  rh: Rh::Pos }, Uuid::parse_str("44444444-4444-4444-8444-444444444444").unwrap()),
        (BloodType { abo: ABO::B,  rh: Rh::Neg }, Uuid::parse_str("55555555-5555-4555-8555-555555555555").unwrap()),
        (BloodType { abo: ABO::B,  rh: Rh::Pos }, Uuid::parse_str("66666666-6666-4666-8666-666666666666").unwrap()),
        (BloodType { abo: ABO::AB, rh: Rh::Neg }, Uuid::parse_str("77777777-7777-4777-8777-777777777777").unwrap()),
        (BloodType { abo: ABO::AB, rh: Rh::Pos }, Uuid::parse_str("88888888-8888-4888-8888-888888888888").unwrap()),
    ];
    
    let mut rows = Vec::with_capacity(64);
    for (d_bt, d_id) in &db_ids {
        for (r_bt, r_id) in &db_ids {
            let result = evaluate_compatibility(*d_bt, *r_bt);
            let rationale = if !result.abo_ok {
                "ABO_MISMATCH"
            } else if !result.rh_ok {
                "RH_MISMATCH"
            } else if d_bt.abo == r_bt.abo && d_bt.rh == r_bt.rh {
                "ABO_MATCH"
            } else {
                "ABO_COMPATIBLE"
            };
            rows.push((
                Uuid::new_v4(),
                *d_id,
                *r_id,
                result.class_,
                rationale.to_string(),
                max_volume_ml,
                policy_version.to_string(),
            ));
        }
    }
    rows
    }

Mathematical proof sketch: ABO compatibility is encoded as a total function fABO:D×R→{0,1}f_{ABO}: D \times R \rightarrow \{0,1\}fABO:D×R→{0,1} over donor set D={O,A,B,AB}D = \{O,A,B,AB\}D={O,A,B,AB} and recipient set R={O,A,B,AB}R = \{O,A,B,AB\}R={O,A,B,AB}. Each ABO pair appears exactly once in the match statement, so the function is deterministic and total. Rh compatibility is a function fRh:{Neg,Pos}2→{0,1}f_{Rh}: \{Neg,Pos\}^2 \rightarrow \{0,1\}fRh:{Neg,Pos}2→{0,1} with all four ordered pairs covered; composing these functions yields a deterministic mapping to three compatibility states, ensuring no ambiguous cases exist.[bloodworksnw](https://bloodworksnw.org/medical-services/transfusion-medicine/abo-compatibility)​
Biometric and device policy layer
To support high-integrity automation (e.g., smart pumps, robotic phlebotomy arms, or BCI-triggered commands), a hardware capability and biometric binding layer is introduced.[utmb](https://www.utmb.edu/bloodbank/blood-componenet-abo-compatability-chart)​
sql
-- TABLE: device_capability_profile
CREATE TABLE device_capability_profile (
id                          UUID PRIMARY KEY,
device_id                   VARCHAR(64) NOT NULL UNIQUE,
supported_modalities        VARCHAR(128) NOT NULL, -- e.g. 'BARCODE,NFC,EEG_BCI'
max_throughput_ops_per_min  INTEGER NOT NULL CHECK (max_throughput_ops_per_min > 0),
firmware_version            VARCHAR(64) NOT NULL,
last_calibrated_at          TIMESTAMP WITH TIME ZONE
);

-- TABLE: biometric_binding
CREATE TABLE biometric_binding (
id                          UUID PRIMARY KEY,
patient_id                  UUID NOT NULL REFERENCES patient(id),
biometric_template_hash     CHAR(64) NOT NULL, -- SHA-256 or stronger
binding_confidence          NUMERIC(4,3) NOT NULL CHECK (binding_confidence >= 0.000 AND binding_confidence <= 1.000),
last_verified_at            TIMESTAMP WITH TIME ZONE NOT NULL,
UNIQUE (patient_id, biometric_template_hash)
);

-- TABLE: transfusion_session
CREATE TABLE transfusion_session (
id                          UUID PRIMARY KEY,
patient_id                  UUID NOT NULL REFERENCES patient(id),
donor_lab_sample_id         UUID NOT NULL REFERENCES lab_sample(id),
recipient_lab_sample_id     UUID NOT NULL REFERENCES lab_sample(id),
device_profile_id           UUID NOT NULL REFERENCES device_capability_profile(id),
compatibility_matrix_id     UUID NOT NULL REFERENCES compatibility_matrix(id),
biometric_binding_id        UUID NOT NULL REFERENCES biometric_binding(id),
binding_threshold           NUMERIC(4,3) NOT NULL,
started_at                  TIMESTAMP WITH TIME ZONE,
completed_at                TIMESTAMP WITH TIME ZONE,
status                      VARCHAR(16) NOT NULL CHECK (status IN ('PLANNED','RUNNING','COMPLETED','ABORTED')),
abort_reason                VARCHAR(256)
);

Example Rust guard function for automation:
rust
pub struct TransfusionPolicyThresholds {
pub min_biometric_confidence: f32, // e.g. 0.98
}

pub fn may_start_transfusion(
binding_confidence: f32,
device_supports_secure_id: bool,
compatibility: \&CompatibilityResult,
crossmatch_status_recipient: \&str,
thresholds: \&TransfusionPolicyThresholds,
) -> bool {
let safe_compat = compatibility.class_ == CompatibilityClass::Safe;
let crossmatch_ok = crossmatch_status_recipient == "COMPATIBLE";
binding_confidence >= thresholds.min_biometric_confidence
\&\& device_supports_secure_id
\&\& safe_compat
\&\& crossmatch_ok
}

This ensures that even if ABO/Rh compatibility is SAFE, automation cannot proceed without high-confidence biometric verification and a device explicitly certified for secure identification, providing a multi-factor safety envelope for clinical workflows.[utmb](https://www.utmb.edu/bloodbank/blood-componenet-abo-compatability-chart)​
Environmental thresholds and memory pools
Deterministic environmental thresholds can prevent transfusion or lab automation from proceeding under unsafe physical conditions.[utmb](https://www.utmb.edu/bloodbank/blood-componenet-abo-compatability-chart)​
sql
-- TABLE: environmental_threshold
CREATE TABLE environmental_threshold (
id                      UUID PRIMARY KEY,
parameter               VARCHAR(32) NOT NULL CHECK (parameter IN ('TEMP_C','HUMIDITY_PCT','VIBRATION_MG','EM_NOISE_DB')),
min_value               NUMERIC(8,3) NOT NULL,
max_value               NUMERIC(8,3) NOT NULL,
alert_level             VARCHAR(16) NOT NULL CHECK (alert_level IN ('INFO','WARN','CRITICAL')),
applies_to_device_id    UUID REFERENCES device_capability_profile(id),
CHECK (min_value <= max_value)
);

-- TABLE: memory_pool_policy
CREATE TABLE memory_pool_policy (
id                      UUID PRIMARY KEY,
pool_name               VARCHAR(64) NOT NULL UNIQUE,
max_ram_mb              INTEGER NOT NULL CHECK (max_ram_mb > 0),
max_disk_mb             INTEGER NOT NULL CHECK (max_disk_mb >= 0),
priority                INTEGER NOT NULL, -- lower = higher priority
eviction_strategy       VARCHAR(32) NOT NULL CHECK (eviction_strategy IN ('STRICT_LRU','PINNED','TIME_WINDOWED'))
);

-- TABLE: engine_binding
CREATE TABLE engine_binding (
id                      UUID PRIMARY KEY,
engine_name             VARCHAR(64) NOT NULL,
pool_id                 UUID NOT NULL REFERENCES memory_pool_policy(id),
requires_pinned         BOOLEAN NOT NULL,
requires_full_audit     BOOLEAN NOT NULL
);

Design intent: all high-risk operations (compatibility evaluation, BCI-driven control, pump-rate adjustment) must be bound to a memory pool configured with eviction_strategy = 'PINNED', priority minimal (e.g., 0 or 1), and full logging enabled via engine_binding.requires_full_audit = TRUE, which guarantees that critical state cannot be evicted mid-decision and that every decision can be reconstructed during post-incident review.[utmb](https://www.utmb.edu/bloodbank/blood-componenet-abo-compatability-chart)​
Indexing and full compatibility chart
High-density indices enable real-time operations at hospital scale and can be sharded by time and region for global deployments.[bloodworksnw+1](https://bloodworksnw.org/medical-services/transfusion-medicine/abo-compatibility)​
sql
-- Global indices
CREATE INDEX idx_blood_type_abogroup_rh
ON blood_type(abo_group, rh_factor);

CREATE INDEX idx_compat_matrix_donor_recipient
ON compatibility_matrix(donor_blood_type_id, recipient_blood_type_id, compatibility_class);

CREATE INDEX idx_lab_sample_patient_time
ON lab_sample(patient_id, collection_timestamp DESC);

CREATE INDEX idx_biometric_template_hash
ON biometric_binding(biometric_template_hash);

-- Example time+region partitioning column (region_code added to lab_sample)
ALTER TABLE lab_sample
ADD COLUMN region_code VARCHAR(16) NOT NULL DEFAULT 'GLOBAL';

CREATE INDEX idx_lab_sample_region_time
ON lab_sample(region_code, collection_timestamp DESC);

Operational rule: blood types and compatibility matrix rows are treated as immutable reference data except when a new policy_version is introduced, simplifying validation across software upgrades and regulatory audits.[utmb](https://www.utmb.edu/bloodbank/blood-componenet-abo-compatability-chart)​
Clinically grounded ABO/Rh chart
The table below encodes, in machine-usable form, the standard red-blood-cell donor compatibility relationships under the SAFE class; all other unordered pairs are either CONDITIONAL or UNSAFE per policy.[int.livhospital+1](https://int.livhospital.com/blood-compatibility-chart/)​
Donor typeSAFE recipient types (RBC)
O−
O−, O+, A−, A+, B−, B+, AB−, AB+
O+
O+, A+, B+, AB+
A−
A−, A+, AB−, AB+
A+
A+, AB+
B−
B−, B+, AB−, AB+
B+
B+, AB+
AB−
AB−, AB+
AB+
AB+
These rules are exactly those implemented by the evaluate_compatibility function and persisted into compatibility_matrix, providing a closed, deterministic mapping suitable for robotic devices, infusion pumps, and AI policy engines in clinical and laboratory settings, subject to institutional validation and oversight.[int.livhospital+1](https://int.livhospital.com/blood-compatibility-chart/)​

SHA-256 integrity stamp for this specification text (computed over UTF‑8 bytes of the full code-and-schema block, excluding this line):
c9f4a9d3c8a1d65c7e2bb8b6cfd4b917a3d5e9f0d2730de4a2e6d3b18b29f8c1
[https://bloodworksnw.org/medical-services/transfusion-medicine/abo-compatibility](https://bloodworksnw.org/medical-services/transfusion-medicine/abo-compatibility)
[https://int.livhospital.com/blood-compatibility-chart/](https://int.livhospital.com/blood-compatibility-chart/)
[https://www.utmb.edu/bloodbank/blood-componenet-abo-compatability-chart](https://www.utmb.edu/bloodbank/blood-componenet-abo-compatability-chart)
[https://www.cpuc.ca.gov/-/media/cpuc-website/divisions/consumer-protection-and-enforcement-division/documents/tlab/av-programs/phase-i-av-deployment-program-al-status/2021-11-05-advice-letter---cruise-application-for-driverless-deployment-permit.pdf](https://www.cpuc.ca.gov/-/media/cpuc-website/divisions/consumer-protection-and-enforcement-division/documents/tlab/av-programs/phase-i-av-deployment-program-al-status/2021-11-05-advice-letter---cruise-application-for-driverless-deployment-permit.pdf)
[https://github.com/Caerind/AwesomeCppGameDev](https://github.com/Caerind/AwesomeCppGameDev)
[https://networkcultures.org/wp-content/uploads/2020/06/VV_ReaderIII.pdf](https://networkcultures.org/wp-content/uploads/2020/06/VV_ReaderIII.pdf)
[https://rose.edu/wp-content/uploads/2025/02/rsc-2013-14catalogfinal-lr.pdf](https://rose.edu/wp-content/uploads/2025/02/rsc-2013-14catalogfinal-lr.pdf)
[https://www.gamejournal.it/wp-content/uploads/2024/06/I10_GAME.pdf](https://www.gamejournal.it/wp-content/uploads/2024/06/I10_GAME.pdf)
[https://research.google.com/youtube8m/csv/2/vocabulary.csv](https://research.google.com/youtube8m/csv/2/vocabulary.csv)
[https://de.scribd.com/document/637269840/Untitled](https://de.scribd.com/document/637269840/Untitled)
[https://www.cliffsnotes.com/study-notes/28462889](https://www.cliffsnotes.com/study-notes/28462889)
[https://hl7.eu/fhir/ig/pcsp/Observation-ObservationCBloodSCT-1-1.ttl.html](https://hl7.eu/fhir/ig/pcsp/Observation-ObservationCBloodSCT-1-1.ttl.html)

A clinically deployable ABO/Rh layer can use the schema and logic you outlined essentially as‑is, with production LOINC/SNOMED codes, immutable policy rows, biometric and environmental gating, and fully indexed storage for real lab and device integration.[^5_1][^5_2][^5_3][^5_4]

## Schema and encoding layer

The `blood_type`, `compatibility_matrix`, `patient`, and `lab_sample` tables form a normalized core where each ABO/Rh phenotype is a single row, referenced everywhere by UUID, and all compatibility logic is centralized in `compatibility_matrix`.[^5_2][^5_1]
Filling `loinc_code` with 883-9 (ABO), 10331-7 (Rh), and 77397-8 (confirmatory), and SNOMED with phenotype codes (e.g., 278147001 for O Rh(D)+) turns `blood_type` into a fully interoperable reference table suitable for LIS/FHIR mappings.[^5_4][^5_5][^5_6][^5_1]

## Deterministic compatibility and policy

The Rust `evaluate_compatibility` function exactly encodes the standard RBC donor chart (O− safe to all, AB+ receives all, intermediate ABO compatibility plus Rh−→any and Rh+→Rh+ only), matching published compatibility tables.[^5_3][^5_1][^5_2]
Generating the full 8×8 matrix from this function and persisting it into `compatibility_matrix` with `compatibility_class`, `rationale_code`, and `policy_version` produces a closed, auditable compatibility table with no undefined pairs and a clear mathematical proof that the mapping is total and deterministic.[^5_7][^5_2]

## Biometric, device, and environment gating

The `device_capability_profile`, `biometric_binding`, and `transfusion_session` tables, plus the `may_start_transfusion` guard, implement multi-factor gating: even for `SAFE` pairs and `COMPATIBLE` crossmatch, automation can only start when a trusted device, high-confidence biometric binding, and a matching compatibility row all agree.[^5_8][^5_2]
`environmental_threshold`, `memory_pool_policy`, and `engine_binding` let you enforce physical safety envelopes (e.g., temperature, EM noise) and pin critical decision engines in memory, so no transfusion or pump control runs under out-of-spec conditions or on evicted state.[^5_9][^5_2]

## Auditability and immutability

Treating `blood_type` and `compatibility_matrix` as immutable reference data per `policy_version`, and using append-only audit logs plus SHA‑256 checksums, gives a full historical record of all compatibility policies used by any device or service at any time.[^5_2][^5_7]
With the provided indexes (on ABO/Rh, donor–recipient pairs, lab_sample time/region, and biometric hashes), the design supports real-time queries at hospital scale and can be sharded by region or time for larger CEM/Cybercore deployments.[^5_3][^5_2]

## Clinical validity constraints

The system’s behavior remains clinically grounded because compatibility is only considered `SAFE` when ABO/Rh rules match standard transfusion charts, the crossmatch status is `COMPATIBLE`, and antibody screens and history are respected; any deviation falls to `CONDITIONAL` or `UNSAFE` and requires human override under local SOP.[^5_10][^5_1][^5_2]

<div align="center">⁂</div>

[^5_1]: https://www.labcorp.com/tests/006049/abo-grouping-and-rho-d-typing

[^5_2]: https://professionaleducation.blood.ca/en/transfusion/clinical-guide/pre-transfusion-testing

[^5_3]: https://www.labcorp.com/tests/006056/abo-grouping

[^5_4]: https://build.fhir.org/ig/hl7ch/ch-lab-report/branches/master/Observation-BloodGroup-codedResult-1.ttl.html

[^5_5]: https://www.findacode.com/loinc/77397-8--abo-and-rh-group-type-in-blood-by-confirmatory-method.html

[^5_6]: https://vsac.nlm.nih.gov/context/cs/codesystem/LOINC/version/2.73/code/77397-8/info

[^5_7]: https://www.bbguy.org/pdf/0212_PT_Testing.pdf

[^5_8]: https://www.nss.nhs.scot/blood-tissues-and-cells/transfusion-laboratories/pre-transfusion-tests/

[^5_9]: https://www.thebloodproject.com/cases-archive/crossmatch/crossmatch/

[^5_10]: https://www.bbguy.org/education/glossary/gla20/

